Drug-Induced Liver Injury Associated with the Use of Nonnucleoside Reverse-Transcriptase Inhibitors
Open Access
- 1 March 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (Supplement) , S80-S89
- https://doi.org/10.1086/381450
Abstract
Human immunodeficiency virus (HIV)-infected patients frequently present with elevated levels of serum transaminases (alanine aminotransferase [ALT] aKeywords
This publication has 12 references indexed in Scilit:
- Drug-Induced Liver InjuryClinical Infectious Diseases, 2004
- A Comprehensive Hepatic Safety Analysis of Nevirapine in Different Populations of HIV Infected Patients*JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Drug-Induced HepatotoxicityNew England Journal of Medicine, 2003
- NNRTI-related or -unrelated hepatotoxicity?Hepatology, 2002
- Reply:Hepatology, 2002
- Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination TherapyThe Journal of Infectious Diseases, 2002
- Lack of Hepatotoxicity Associated With Nonnucleoside Reverse Transcriptase InhibitorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsHepatology, 2002
- Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyAIDS, 2001
- Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus InfectionJAMA, 2000